Related Experiment Videos

Percutaneous atherectomy of occlusive peripheral vascular disease: stenoses and/or occlusions

G Dorros1, R F Lewin, N Sachdev

  • 1Department of Cardiology, St. Luke's Medical Center, Milwaukee, WI.

Insights

Percutaneous atherectomy effectively treated peripheral artery disease in 131 patients, achieving high success rates with minimal complications. This minimally invasive procedure showed a low lesion recurrence rate, offering a safe treatment option for claudication and critical limb ischemia.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Peripheral Artery Disease Treatment

Background:

  • Peripheral artery disease (PAD) significantly impacts patient quality of life.
  • Traditional treatments for PAD carry risks and limitations.
  • Percutaneous atherectomy offers a less invasive approach to PAD management.

Purpose of the Study:

  • To evaluate the safety and efficacy of percutaneous atherectomy using the Simpson Atherocath in patients with PAD.
  • To assess the histopathological findings of atherectomy specimens.
  • To determine the early recurrence rate of treated lesions.

Main Methods:

  • A prospective study involving 131 patients undergoing percutaneous atherectomy with the Simpson Atherocath.
  • Patients presented with claudication or critical limb ischemia.
  • Successful procedure and complication rates were recorded, along with histopathological analysis and early angiographic follow-up.

Main Results:

  • Successful atherectomy was achieved in 98% of stenoses and 100% of occluded vessels.
  • No serious complications leading to limb loss or emergency surgery were reported.
  • Histopathology revealed atheromatous plaque (66%), tunica media (45%), and thrombus (30%), with occluded vessels more likely to contain thrombus and tunica media.
  • Early follow-up showed a low lesion recurrence rate of 17%.

Conclusions:

  • Percutaneous atherectomy is a safe and effective treatment for stenotic and occluded peripheral arteries.
  • The procedure demonstrates high technical success and a favorable safety profile.
  • Low lesion recurrence rates suggest long-term benefits for patients with PAD.

Related Concept Videos